阿托伐他汀治疗急性缺血性脑梗死的效果  

Effect of atorvastatin on acute ischemic cerebral infarction

作　　者：崔艳春 Cui Yanchun(Tangshan City, Hebei Province Abundant South Area of Yellow Area Town Center Hospital, Internal Medicine,Tangshan,Hebei 063307)

机构地区：[1]河北省唐山市丰南区黄各庄镇中心卫生院内科,河北唐山063307

出　　处：《中外女性健康研究》2020年第8期28-29,46,共3页Women＇s Health Research

摘　　要：目的:探讨阿托伐他汀治疗急性缺血性脑梗死的效果。方法:对于2018年5月至2019年5月前来本院就诊的急性缺血性脑梗死患者,按标准从中选择200例作为研究对象,按奇偶数法随机分为两组,各组病例数一致。参照组患者接受抗血小板凝聚等常规治疗,研究组患者在参照组基础上加用阿托伐他汀治疗。治疗14d后,比较两组患者的NIHSS评分、血脂水平、ADL评分。结果:治疗后,研究组患者NIHSS评分为(10.04±1.32)分、ADL评分为(54.87±3.11)分,均优于参照组,差异具有统计学意义(P<0.05)。治疗后,研究组血脂各项指标均优于参照组,差异具有统计学意义(P<0.05)。结论:对急性缺血性脑梗死患者在常规治疗的基础上给予阿托伐他汀治疗可以更好地调节患者的血脂水平,改善患者的自理能力,促进患者神经功能的恢复,效果更为确切。Objective:To investigate the effect of atorvastatin on acute ischemic cerebral infarction.Methods:For patients with acute ischemic cerebral infarction who came to our hospital from May 2018 to May 2019,200 patients were selected according to the criteria.The odd-even method was randomly divided into two groups.The number of cases was consistent.Patients in the reference group received conventional treatment such as antiplatelet aggregation,and patients in the study group were treated with atorvastatin on the basis of the reference group.After 14 days of treatment,the NIHSS score,blood lipid level,and ADL score were compared between the two groups.Results:After treatment,the NIHSS scores of the study group were(10.04±1.32)and the ADL scores were(54.87±3.11),which were superior to the reference group,and the difference was statistically significant(P<0.05).After treatment,the blood lipids of the study group were superior to the reference group,and the difference was statistically significant(P<0.05).Conclusion:The administration of atorvastatin on patients with acute ischemic cerebral infarction can better regulate the blood lipid level,improve the quality of life of patients and promote the recovery of neurological function.

关 键 词：急性缺血性脑梗死 阿托伐他汀 抗血小板凝聚治疗 

分 类 号：R74[医药卫生—神经病学与精神病学]